Creative Planning
BRTX icon

Creative Planning’s BioRestorative Therapies BRTX Stock Holding History

Creative Planning’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.17K Buy
+21,739
New +$6.36K ﹤0.01% 4235

Other funds holding BRTX

VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Creative Planning's BRTX Position: Q2 2026 in Review

Creative Planning opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 21,739 shares worth $8.17K. The stake represents ﹤0.01% of the portfolio and ranks #4235 among its holdings.

15 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • Creative Planning held 21,739 shares of BioRestorative Therapies worth $8.17K as of Q2 2026.
  • BioRestorative Therapies was a new Creative Planning position in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4235 holding.
  • 15 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.